DocMorris AG Announces 2026 Financial Calendar
ZURICH, SWITZERLAND – July 17, 2025 – DocMorris AG, a prominent european digital health and pharmacy services provider, has released its financial reporting schedule for 2026. The company will present its full-year 2025 results and provide an outlook for 2026 on March 19, 2026, via a conference call and webcast. This will be followed by a Q1/2026 trading update on April 16,2026.
The companyS ordinary general meeting is scheduled for May 12, 2026, in Zurich. the first-half 2026 results will be announced on August 19, 2026, also accompanied by a conference call and webcast. The year’s reporting concludes with a Q3/2026 trading update on october 15, 2026.
About DocMorris AG:
DocMorris AG is a leading European entity specializing in online pharmacies, marketplaces, and professional healthcare solutions, with a critically important presence in germany and other European nations. Its operations are largely supported by a highly automated logistics center in Heerlen, netherlands, capable of processing 27 million packages annually. The company also operates a leading marketplace for health and care products in Southern Europe through its Spanish and french subsidiaries. DocMorris aims to establish a digital health ecosystem enabling individuals to manage their health conveniently. In 2024, approximately 1,600 employees across Germany, the Netherlands, Spain, France, Portugal, and Switzerland served over 10 million active customers, generating external sales of CHF 1,085 million. DocMorris AG shares are listed on the SIX Swiss Exchange under the ticker DOCM (Valor 4261528, ISIN CH0042615283). Further details are available at corporate.docmorris.com.